Leptin Sensitivity in Nonobese Glucagon-Like Peptide I Receptor −/− Mice
The DOI matches its Crossref record.
Abstract
Glucagon-like peptide I (GLP-I) stimulates glucosedependent insulin secretion and inhibits food intake in the central nervous system. Because leptin reduces food intake but inhibits insulin secretion, we examined leptin action in mice with a null mutation in the GLP-I receptor. Intracerebroventricular leptin administration inhibited food intake in both wild-type and GLP-I receptor (GLP-IR) −/− mice, and daily intraperitoneal administration of leptin for 2 weeks produced comparable reductions in food intake and body weight in control and GLP-IR −/− mice. Glucose tolerance was improved in both wild-type and GLP-IR −/− mice, whether pair fed or leptin treated; however, blood sugars were significantly lower in the leptin-treated GLPIR −/− mice following oral glucose challenge (P < 0.01). Glucose-stimulated insulin was reduced in both pair-fed and leptin-treated mice (P < 0.01–0.001); however, insulin levels were significantly lower in leptin-treated versus pairfed GLP-IR −/− mice (P < 0.01). A single leptin injection had no effect on glucose tolerance in GLPIR −/− mice, but decreased hepatic PEPCK mRNA in both wild-type and GLP-IR −/− mice. The improvement in blood glucose excursion, despite lower levels of glucose-stimulated insulin in lean leptin-treated GLP-IR −/− mice, suggests that leptin may have beneficial effects on control of blood glucose in the absence of obesity. Furthermore, the greater effects of leptin on glucose and insulin in leptin-treated versus pair-fed GLP-IR −/− mice raises the possibility that disruption of GLP-I signaling modifies the sensitivity to leptin in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
Drucker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2929 · Cited by 579
Self-citationGLP-1 physiology informs the pharmacotherapy of obesity
Drucker, D. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101351 · Cited by 510
Self-citationLeptin directly regulates bone cell function in vitro and reduces bone fragility in vivo
Cornish, J., Callon, K., Bava, U., Lin, C., Naot, D., Hill, B., Grey, A., Broom, N., Myers, D., Nicholson, G., et al. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750405 · Cited by 472
“…of leptin on bone mass, since central administration of leptin dramatically decreases circulating insulin concentrations (Kamohara et al. 1997, Scrocchi et al. 1997, Shi et al. 1998, Tannenbaum et al. 1998), via changes in insulin sensitivity mediated by the autonomic nervous system (Mizuno…”
BackgroundHansotia, T., Baggio, L. L., Delmeire, D., Hinke, S. A., Yamada, Y., Tsukiyama, K., Seino, Y., Holst, J. J., Schuit, F., & Drucker, D. J. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1326 · Cited by 309
Self-citation
Metadata
- Authors
- Scrocchi, L. A., Brown, T. J., & Drucker, D. J.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1997-12-01
- Volume
- 46
- Issue
- 12
- Pages
- 2029-2034
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1986171586
- Cited by
- 22
- References
- 0
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Leptin Sensitivity in Nonobese Glucagon-Like Peptide I Receptor −/− Mice. https://app.cochat.ai/papers/10.2337/diab.46.12.2029
- The paper
- Scrocchi, L. A., Brown, T. J., & Drucker, D. J. (1997). Leptin Sensitivity in Nonobese Glucagon-Like Peptide I Receptor −/− Mice. Diabetes. https://doi.org/10.2337/diab.46.12.2029
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.